diagnosis and treatment of infertility, first/second/third generation IVF (including
egg/sperm donation), microsperm retrieval, embryo freezing and resuscitation, artificial
insemination (including husband's sperm and sperm donation), paternity testing, chromosomal
disease
diagnosis, high-throughput gene sequencing, endometrial receptivity gene testing and other
clinical
technology applications. Many of these technologies are at the leading level both domestically
and
internationally.
Why is there no unified answer to the success rate of IVF in Georgia?
Searching for "success rate of IVF in Georgia", we can often see different figures: some pages write clinical pregnancy rate, some write success rate of embryo transfer, and some count the cumulative results after multiple transfers. The figures look close, but the actual statistics may not be the same thing.
As of August 2026, as far as publicly available information is concerned, Georgia has not yet formed a national public database that can be queried by age, treatment method, hospital and live birth outcome, like CDC in the United States and HFEA in the United Kingdom. Therefore, the success rate of Georgian test tubes on the Internet mostly comes from the data published by medical institutions themselves, which cannot be directly regarded as the national average of Georgia.
For example, the pregnancy rate of the self-owned germ cell project published by official website, a Georgian institution, is about 35%-55%, but the page does not fully show the patient's age composition, cycle cancellation, sample number and live birth outcome, so this range can only be used as a reference for the public information of the institution, and cannot be directly applied to every patient.
The real reference question is not "What is the success rate of IVF in Georgia", but:
What is the chance of getting a live birth in a complete ovum retrieval cycle when the age, ovarian reserve, semen condition and previous treatment experience are close?

Understand the four statistical caliber of success rate first.
The same hospital can publish multiple success rates at the same time, and these figures may be established. The main difference lies in the difference between the statistical endpoint and denominator.
What does the data name stand for?
Embryo implantation rate The proportion of gestational sac formed in transplanted embryos does not represent whether a transfer can give birth.
The proportion of clinical pregnancy confirmed by ultrasound after transplantation has not been deducted from the subsequent pregnancy interruption.
The proportion of live birth outcome after live birth treatment needs to be confirmed by cycle, egg retrieval or transplantation.
The cumulative live birth rate of all embryos obtained by taking eggs at one time, after fresh and subsequent freeze-thaw transfer, the observation time of comprehensive live birth results is longer, usually higher than that of single transfer data
When explaining the data of assisted reproduction, CDC clearly pointed out that the success rate would be affected by age, infertility reasons, previous pregnancy history, previous treatment times and specific technical paths. Average data cannot be equated with individual results. The cumulative success rate currently adopted by CDC can be included in the related embryo transfer outcomes within 12 months after one egg retrieval.
Therefore, when seeing a Tbilisi test-tube hospital announce "high success rate", we need to continue to confirm four questions:
Is the number a clinical pregnancy rate or a live birth rate?
Is the denominator the startup cycle, egg retrieval cycle or embryo transfer cycle?
Are they counted by age and germ cell source?
Does it include the cumulative results after multiple freeze-thaw transplants?
Without these conditions, it is meaningless to compare percentages separately.
Age changes are more worthy of attention than national differences.
There are many factors that affect the success rate of IVF in Georgia, among which the correlation between age and egg quality is relatively stable. Countries and hospitals can influence medical processes, cultivation environment and program implementation, but they cannot eliminate the biological changes brought about by age.
The data of 2023 published by HFEA in Britain can be used as an international reference to understand the age difference. When using patients' own eggs for fresh embryo transfer, the clinical pregnancy rate of people aged 18-34 is about 41%, 35-37 is about 34%, 38-39 is about 25%, and 43-44 is about 9%. In the same statistics, the live birth rate of fresh embryo transfer for people aged 18-34 is about 35%, and that for people aged 43-44 is about 5%. These figures are British regulatory data, not Georgian data, but they can illustrate the direction in which age affects the results.
According to this, Georgia's assisted reproductive population can be divided into several evaluation paths:
Under 35 years old, ovarian reserve is acceptable:
Focus on the ovulation promotion scheme, laboratory culture stability, blastocyst formation and single embryo transfer strategy, not just the average success rate on the publicity page.
35-39 years old, with a certain decline in ovarian reserve:
It is necessary to evaluate AMH, the number of follicles in the basal sinus, the number of previously obtained eggs, the proportion of mature eggs and the development of embryos at the same time. The key at this stage is usually whether a sufficient number of embryos with potential for further development can be obtained.
Over 40 years old or many times of treatment failed to achieve ideal results:
The reference value of the pregnancy rate of a transplant will decrease, and more attention should be paid to the cumulative live birth rate, the expected number of egg retrieval, the number of embryos that can be formed and the overall time planning.
Male factors are more obvious:
In addition to routine semen analysis, it is necessary to combine sperm concentration, motility, morphology and further examination considered necessary by doctors to determine whether it is necessary to adopt laboratory schemes such as intracytoplasmic sperm injection.
A "success rate impact map" to judge your own core variables.
The success rate of IVF in Georgia can be divided into three consecutive stages. There are obvious shortcomings at any stage, which may affect the subsequent results.
Egg retrieval stage: Are there enough eggs available?
This stage is mainly affected by age, AMH, basal sinus follicle number, basic hormones, ovulation induction reaction and previous surgical history.
AMH value can not predict pregnancy alone, but it can help doctors estimate the ovarian response to ovulation drugs and the number of eggs that may be obtained. People of the same age may still have obvious differences in ovarian reserve and actual egg retrieval results.
Laboratory stage: Can an embryo with developmental potential be formed?
Getting an egg doesn't necessarily mean forming an embryo. The proportion of mature eggs, normal fertilization rate, cleavage, blastocyst formation rate and frozen resuscitation performance will all affect the number of transplantable embryos.
Related research in European reproductive medicine points out that the application of blastocyst culture and vitrification technology is related to the improvement of cumulative live birth rate. The cumulative live birth rate is closer to the actual result obtained after a complete egg retrieval cycle than the pregnancy rate of single transplantation.
Transplantation stage: does the embryo match the uterine environment?
After entering the stage of transplantation, it is necessary to evaluate the thickness and shape of endometrium, uterine cavity, endocrine status, embryo quality and transplantation time.
According to HFEA data in Britain, the average clinical pregnancy rate of frozen-thawed embryo transfer in 2023 is about 39%, and the average live birth rate is about 33%. However, the results have a great relationship with the age at the time of egg retrieval, not just the age at the time of transplantation. This data still belongs to the overall statistics of Britain, which can only be used to understand the statistical logic and cannot directly represent the level of Georgian hospitals.
To judge whether the data of Tbilisi test tube hospital is credible, you can check it like this.
When choosing a test tube hospital in Georgia, you don't need to pursue an eye-catching number, but you should ask the hospital to provide data that can be explained.
You can check the following contents:
Data stratified by age.
At least distinguish between people under 35 years old, 35-37 years old, 38-40 years old and over 40 years old, instead of counting all patients together.
While providing pregnancy rate and live birth rate.
There is only pregnancy rate but no live birth outcome, and the information is still incomplete.
Explain the denominator of the data.
The data calculated by transplantation is usually higher than that calculated by startup cycle or egg retrieval cycle, because cycles that have not entered the transplantation stage may not be included.
Open the sample size and statistical year.
Dozens of cycles are different from thousands of cycles in digital stability; Years of accumulated data may also mask recent changes in technology and patient structure.
Explain the composition of patients.
Whether the hospital accepts more elderly people, declining ovarian reserve or unsuccessful repeated treatment will directly affect the overall data. Patients with different structures cannot be ranked simply.
Asking for complete cycle results.
Instead of asking only the success rate of a single transfer, it is better to ask the number of eggs, mature eggs, normal fertilization, blastocysts and the cumulative live birth results after all embryos are used.
Users are also concerned about: how to improve the judgment of the scheme by going to Georgia to do test tubes?
Before departure, we should try our best to complete the basic reproductive assessment, including AMH, basic hormones, sinus follicle count, thyroid function, infectious disease screening, uterus and uterine cavity examination, and the related examination of male semen. Those who have done assisted reproduction in the past should also sort out the drugs for promoting ovulation, the number of eggs obtained, the number of mature eggs, the number of fertilized eggs, the records of embryo culture and the outcome of transplantation.
After getting the Georgian hospital plan, don't just look at the drug name, you can further confirm:
How many eggs the doctor expects to get, and what is the basis;
What kind of fertilization and embryo culture paths are planned;
Whether it is recommended to raise cysts and how to recover them when blastocysts are not formed;
Under what circumstances do you cancel fresh transplantation and change to freeze-thaw transplantation?
What links will be adjusted in the next cycle when an available embryo is not obtained in one egg retrieval?
Whether the success rate mentioned by the hospital belongs to the same statistical group as its own age and medical history.
The clearer these problems are, the easier it is for the average figures on the Internet to be translated into treatment expectations that individuals can understand.
Summary: The success rate of test tubes in Georgia should be based on "individual stratification", not just the national label.
There is no uniform value for the success rate of IVF in Georgia. The data published by institutions can provide clues, but it is necessary to distinguish between pregnancy rate and live birth rate, single transplantation and cumulative cycle, self-owned germ cell program and other individualized fertility programs.
For those who are going to Tbilisi for assisted reproductive evaluation, age, ovarian reserve, semen condition, previous treatment experience, embryo culture ability and transplantation strategy all determine the actual results.
* * A more reliable way to judge is to match the live birth data of the same age, the same scheme and the same statistical caliber with the personal examination data, and give priority to the cumulative results of one egg retrieval and all related embryo transfer. * * Any single success rate divorced from age, patient structure and statistical caliber is not suitable as the basis for independent decision-making.
🏥 Located in downtown Bishkek, the capital of Kyrgyzstan, near the National Museum and Victory Square. It is the first Chinese-invested, officially licensed assisted reproductive hospital in the country. Founded and directly operated by Mr. Chen Yinuo (EnoChan), the center specializes in high-level fertility services including PGT (3rd generation IVF) and legal third-party reproduction for global clients, especially Chinese patients.
🌷 Technology-Assisted Fertility, Fulfilling Dreams · Patience · Integrity · Professionalism

